星凱控股(01166.HK)兩名執行董事涉及訴訟
星凱控股(01166.HK)公布,原告CS Asia Opportunities Master Fund於香港高等法院向一名周氏就因違反據稱由原告與周氏訂立之日期為2018年5月31日的「股權互換交易確認書」而結欠的未償還金額展開法律程序。原告要求的未償還金額為1,243.4萬美元,另加利息等。
公司指,得悉原告已採取行動,將公司執行董事即周禮謙及周志豪納入該程序中,有關指稱周禮謙及/或周志豪就周氏就股權互換交易確認書所結欠金額作出的口頭擔保;周禮謙及周志豪已聘請法律顧問受理該程序及作出抗辯,並於今年6月2日分別作為第二及第三被告納入該程序。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.